Project Grant K01DK140610

Award Date 5/15/25
Completion Date 3/31/30
Dollars Obligated $115K
Federal Grant Program
93.847
Assistance Type
Project Grant
Place of Performance
Chapel Hill, NC 27599, USA
Similar Awards
This $148,568 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will fund research to elucidate the mechanisms of Notch signaling in intestinal stem cells and their niche cells. The research aims to define how intestinal stem cells maintain Notch signaling and self-renewal in the absence of Paneth cells, as well as the role of Notch-dependent...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) is designed to elucidate the role of deep crypt secretory (DCS) cells in colonic inflammation and tissue repair. The $551,112 award, which runs from September 2024 to June 2029, will support research at Children's Hospital Los Angeles to: 1) test whether impaired DCS cell responses...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) provides $502,752 to The Washington University in St. Louis to investigate the role of endoplasmic reticulum stress in innate lymphoid cells and their relationship to inflammatory bowel disease. The 5-year research program, led by Siyan Cao, M.D., Ph.D., seeks to elucidate the mechanistic links between cellular...
This Project Grant award from the National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases provides $243,723.52 to the University of North Carolina at Chapel Hill from February 1, 2021 to April 30, 2022. The funding supports research into the effects of the transcription factor SOX9 on the cell cycle of intestinal stem cells. Specifically, the grantee aims to explore the transcriptomic effects of varying SOX9 levels on genes involved in the cell cycle....
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $497,370 project grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to the Regents of the University of Michigan. The grant, titled "CD45 Mediated Regulation of PMN Function During Intestinal Inflammation", will fund research to elucidate the effects of neutrophil-specific loss of the CD45 phosphatase on intestinal inflammation and repair. The project...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $493,470 to the University of Arizona to conduct research on the impact of the Aim2 gene on intestinal stem cell differentiation during inflammation. The research aims to identify novel innate immune targets, cellular signaling pathways, and microbial triggers that can redirect...
This Project Grant award provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research on the role of blood endothelial cells in intestinal regeneration and inflammatory bowel disease. The $155,443 award to Yale University aims to gain a comprehensive understanding of how blood endothelial cells contribute to intestinal repair after injury and how their...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $220,930 to The Medical University of South Carolina to elucidate the role of Myosin 5B in microvilli assembly and in the pathogenesis of Crohn's disease. The research aims to investigate how Myosin 5B regulates microvilli assembly in the intestine and the susceptibility of disordered...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will support research to investigate the role of epigenetic memory in intestinal stem cell (ISC) function and regeneration. The award provides $364,324 in funding to The Regents of the University of California, San Francisco (UCSF) from July 2024 to March 2027. The research aims to characterize...
The federal Project Grant award K08DK140604, funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research into the regulation of signaling pathways that mediate intestinal epithelial cell injury in necrotizing enterocolitis (NEC), a devastating gastrointestinal disease affecting preterm infants. The $522,342 award will enable the University of North Carolina...

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a 5-year, $115,288 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to the University of North Carolina at Chapel Hill (UNC-CH). The grant supports research led by Dr. Joseph Burclaff, a mentored early-career investigator, to study how the transcription factor SOX9 regulates mitochondrial metabolism and pro-inflammatory signaling in human intestinal stem cells. The research aims to provide insights into the mechanisms underlying inflammatory bowel disease development. The project leverages expertise from Dr. Burclaff's mentor, Dr. Scott Magness, as well as additional co-mentors, to build Dr. Burclaff's capabilities in metabolism, transcriptional regulation, and inflammatory bowel disease research. The findings could lead to a better understanding of intestinal stem cell biology and inform potential therapeutic interventions.

Generated 5/13/25, 2:13 AM